PULSE
INSIDERPYCPYC THERAPEUTICS LIMITED: 3 insiders bought $35.3BINSIDERUPBDUPBOUND GROUP, INC.: 6 insiders bought $1.2MINSIDERBBTXBambusa Therapeutics, Inc.: 3 insiders bought $58.6MINSIDERKOVKORVEST LTD: 3 insiders bought $34.1MINSIDERANAUTONATION, INC.: 3 insiders bought $1.4MSHORTSPCTPCT utilization hits 100%, highest level in 52 weeks; availability plunges to 7.1%, down 43% in one week.NEWSCNKCNK Morgan Stanley upgrades to Overweight, raises target 11% to $50 ahead of Q3 earnings Thursday.SHORTSUSOUSO SI utilization surges to 99.61%, highest level in nearly a year, as short sellers face near-complete lending…NEWSCSCOCSCO Morgan Stanley downgrades to Equal-Weight, cuts target to $120 from $135, citing gross margin pressure in FY27.SHORTSMFGMFG SI utilization hits 100%, matching 52-week high; availability falls to 6.5% of short interest, lowest since…SHORTSTMTM short interest utilization hits 100%, matching the 52-week high, as availability plummets to 2.9% of short…NEWSULCCULCC Deutsche Bank upgrades to Buy with $10 price target, up from Hold at $7, implying 41% upside from Monday's close.NEWSPAYCPAYC downgrade to Neutral from Buy by BTIG analyst Allan Verkhovski, Nov 5. Stock at $268.16, up 21% over past month.…NEWSJBLUJBLU upgrades to Buy on 83% price target hike from Deutsche Bank.MACROUSD/MXN −1.44%, a 2.4σ moveMACROAUD/USD +0.67%, a 1.8σ moveMACROUSD/INR −0.47%, a 1.6σ moveMACROJapan 5Y −6bp, a 1.6σ moveNEWSGTMGTM Piper Sandler upgrade to Neutral from Underweight, price target raised to $4.00 from $3.00, 33% upside implied at…NEWSAAMIAAMI Morgan Stanley upgrade lifts target to $110, up 13% from prior $97, shifting to Overweight from Equal-Weight on…NEWSLYNXLYNX upgraded to Outperform by Baird; stock down 20% in one day as earnings miss weighs.NEWSMTRNMTRN Seaport upgrades to Buy, sets $250 target after January downgrade.NEWSUNPUNP Baird Cuts Rating to Neutral, Target Falls 9.9% to $310SHORTSEWTEWT short interest surges 27% in a week to 8% of float, as Taiwan ETF faces selling pressure. Cost to borrow edges up…SHORTS5201[5201](/s/tsejse/5201) cost to borrow jumped to 2.41% on Nov 3, up 153% in one week from 0.97%. Availability remains…SHORTSJPM.PRLJPM.PRL short interest plummets 40.6% in one week to 0.0014% of free float, marking continued retreat from October…SHORTSHOSHOS short interest surges 20% in one session to 10.3M shares, yet borrow availability remains exceptionally loose at…NEWSSTVNSTVN William Blair cuts to Market Perform from Outperform; stock down 31% since Nov 3 earnings miss, now $13.44.NEWSATECATEC UBS downgrades to Neutral, cuts price target 43% to $8.50.SHORTSCODICODI cost to borrow surges to 0.48%, up 163% over one week, as shares to lend tighten sharply.
Proprietary financial data since 2012

Better data.
Better decisions.

ORTEX builds its own market data: short interest estimates, index rebalance forecasts, stock scores and 134 alternative datasets, on one set of identifiers. License it for your desk, or use it on the ORTEX platform.

listings priced
125,000+
datasets
22
markets
50+
history from
1964
AMAMDNasdaq · Advanced Micro Devices, Inc.
LIVE
SI % of Free Float
2.3%
Cost to Borrow
0.17%
Availability
Ample
Days to Cover
1.77

Measured, not claimed.

All the evidence →
Short interest
95%

of estimates within one percentage point of free float of the official figure, across 2.1m official prints.

Index rebalance
85%

of add and delete calls right the day before the announcement, every scheduled review since 2018 across 46 indices; 82% three weeks out.

Alternative data
44 days

median lead on reported revenue across the 54 significant, out-of-sample leads measured.

Government trades
< 1 min

from publication to the ORTEX feed, for all three branches, paper filings included.

Insider transactions
1.6x

the insider trading days of the leading global aggregator, from reading regulators directly.

Options
3.7bn

option contract records: every listed US contract, every day since 2012.

ORTEX data is also distributed through Nasdaq Data Link, Benzinga Data Marketplace, Exchange Data International and Smartkarma.

The data layer

Data you can’t get from a terminal.

ORTEX estimates, forecasts and models, and data collected directly from regulators, exchanges and publishers, each one scored against the official record where there is one.

All 22 datasets in the catalog →Plus insider and government trades, buybacks, ownership, analysts, fundamentals, events, prices, ETFs and logos.
ORTEX for institutions

One integration. Twenty-two datasets.

Proprietary market data for hedge funds, asset managers, quantitative researchers, banks, brokers and financial platforms, with dedicated support and a trial on your own universe before you license.

Point-in-time history

Every value dated to when the market could first know it. Built for research and backtesting.

One security master

Ticker and exchange, ISIN, FIGI and ORTEX identifiers across every dataset, so any one joins onto any other.

Delivery your way

REST API, whole-market daily files over SFTP or S3, CSV, Python and Excel.

License what you need

Individual datasets or the whole stack, from a research seat to redistribution.

One data ecosystem

Choose how you use ORTEX.

Building charts into a product? See ORTEX Charts, our JavaScript charting library.

Pricing

The platform, or the data itself.

For individual investors

The ORTEX platform

Start free, no card required. Priced in your local currency.

ORTEX Basic
Core datasets: delayed short interest, analysts, insiders and fundamentals
$49/mo
ORTEX Advanced
Real-time short interest, options, signals, stock scores and ORTEX AI
$149/mo
Index Rebalance add-on
Forecasts for 131 indices, with probability and flow; requires Advanced
$99/mo
For professional teams

ORTEX data licensing

Priced by dataset, coverage and delivery, for research, risk, systematic trading and redistribution.

  • ✓Data licensing by dataset or bundle
  • ✓Whole-market daily files
  • ✓Point-in-time history
  • ✓Redistribution and OEM
  • ✓Custom universes and trials
FAQ

Common questions.

What is short interest?+

Shares sold short, usually shown as a percentage of the free float (the shares actually available to trade). High short interest means a crowded bet against the stock, and it is a key ingredient in squeeze setups.

How is ORTEX short interest different from the exchange numbers?+

Exchange short interest is a twice-monthly snapshot (positions as of the 15th and the last business day of the month) published about seven business days later, so the official print is already 11 to 12 days old the day it lands, and close to four weeks old just before the next one arrives. ORTEX models short interest from securities-lending data instead and updates the estimate through the trading day, alongside cost to borrow, availability, utilization and days to cover. Figures are ORTEX estimates and revise as new lending data arrives.

How accurate are ORTEX estimates?+

Every estimate is scored against the official record. Since August 2023, 95% of ORTEX short interest estimates were within one percentage point of free float of the official figure, across 2.1 million official prints in the US, Canada, Australia and Hong Kong. Index rebalance forecasts are scored after every review: 85% of add and delete calls were right the day before the announcement, every scheduled review since 2018 across 46 indices.

How is ORTEX data licensed and delivered?+

Every dataset can be licensed on its own or together, and delivered over the REST API (JSON or CSV), as whole-market daily files over SFTP or S3, through the Python SDK and Excel add-in, or on the ORTEX platform. Every dataset shares one set of identifiers, and trials with history are available on your own universe.

What is the cost to borrow (borrow fee)?+

The annualized fee a short seller pays to borrow shares. A rising borrow fee means the lending market is tightening, which makes shorts more expensive to hold.

Do I need a credit card to try ORTEX?+

No. A free account takes under a minute and needs no card. Upgrade to Basic or Advanced when you want more, and manage or cancel your plan in the app at any time.

Can I get the data into my own tools?+

Yes. Everything ships over a documented REST API and Python SDK, and as a native Excel add-in, so the same numbers reach your models and spreadsheets without re-keying. API plans start with a free TEST key.

Which markets does ORTEX cover?+

Prices and reference data for 125,000+ listings from 1964, daily short interest for 52,700+, insider transactions from more than 50 markets, 17,700+ ETFs and 134 alternative datasets from more than 50 countries. The data catalog lists coverage and history for every dataset.

More questions? Start free and see the data, or talk to us.